Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. (Q54689509)

2 June 2018

title

Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. (English)

1 reference

2 June 2018

0 references

6

1 reference

2 June 2018

Lance A. Liotta

9

object named as

Lance A Liotta

1 reference

2 June 2018

author name string

Alessandra Silvestri

1

1 reference

2 June 2018

Alfonso Colombatti

2

1 reference

2 June 2018

Valerie S Calvert

3

1 reference

2 June 2018

Jianghong Deng

4

1 reference

2 June 2018

Enzo Mammano

5

1 reference

2 June 2018

Francesco De Marchi

7

1 reference

2 June 2018

Donato Nitti

8

1 reference

2 June 2018

Emanuel F Petricoin

10

1 reference

2 June 2018

Mariaelena Pierobon

11

1 reference

2 June 2018

publication date

1 March 2010

1 reference

2 June 2018

published in

Laboratory Investigation

1 reference

2 June 2018

volume

90

1 reference

2 June 2018

page(s)

787-796

1 reference

2 June 2018

issue

5

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.47

exact match

0 references

cites work

The microenvironment of the tumour-host interface

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

The tumor cell-host organ interface in the early onset of metastatic organ colonisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Targeting the epidermal growth factor receptor in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Targeting the mTOR signaling network in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Evaluation of non-formalin tissue fixation for molecular profiling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Microdissection is essential for gene expression profiling of clinically resected cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.47

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2010.47

1 reference

2 June 2018

Dimensions Publication ID

0 references

1 reference

2 June 2018